Search Results
Dec 02, 2025, 09:00 ET TQ Therapeutics GmbH Enters into Technology Access Agreement with Kytopen
to deliver transformative therapies to patients."For further information:Kytopen:Investor Contact:Michael Chiu PhD., [email protected] and Corporate Development Contact:Kevin
More news about: Kytopen
Dec 02, 2025, 08:40 ET Acclinate Recognized as a Vet100 Fastest-Growing Veteran-Owned Business
meaningful impact can—and must—coexist.Veteran-Led Leadership That Fuels the MissionAcclinate is led by CEO and Co-Founder Del Smith, PhD, an Air Force veteran whose service shaped his belief in accountability, integrity, and building systems that serve those who are often overlooked. That
More news about: Acclinate
Dec 02, 2025, 08:30 ET CENTURY LITHIUM ACHIEVES HIGH RECOVERY OF RARE EARTH AND CRITICAL ELEMENTS FROM PRIMARY LEACH SOLUTIONS
centurylithium.com. ON BEHALF OF CENTURY LITHIUM CORP.WILLIAM WILLOUGHBY, PhD., PE President & Chief Executive Officer
More news about: Century Lithium Corp.
Dec 02, 2025, 08:00 ET Clairity Unites Pioneers In Medicine And Technology To Redefine Predictive AI For Human Health
risk. Using the mammogram they already have makes better risk information both accessible and respectful of their time." Charles Taylor, PhD — Professor of Medicine and Computational Engineering and Sciences, University of Texas at Austin, Founder and Former CTO, HeartFlow. Dr. Taylor
More news about: Clairity
Dec 02, 2025, 08:00 ET Syantra Inc. to Showcase Breakthrough Research on Immune Reprogramming in Breast Cancer at SABCS 2025
white blood cells and platelets, activating distinct immune and stress-response pathways that mirror those found in tumor cells," said Olesya Kharenko, PhD, Syantra Principal Scientist. "This work establishes a foundation for employing blood-based biomarkers as key elements in identifying, and possibly
More news about: Syantra Inc.
Dec 02, 2025, 08:00 ET SimBioSys and Ricoh 3D for Healthcare to Spotlight AI-Powered 3D Visualization in Webinar Featuring Clinical Use of TumorSight™ Viz
surgical planning, including case examples recently featured by ABC News Digital and Good Morning America. Dr. Reid will be joined by Lexi Gormley, PhD, Senior Clinical Applications Specialist at Ricoh 3D for Healthcare, with moderation by Barry Rosen, MD, FACS, Chief Medical Officer of SimBioSys."With
More news about: SimBioSys
Dec 02, 2025, 07:09 ET American Liver Foundation Hosts the 34th Annual Irwin M. Arias Symposium
Symposium is co-chaired by Sangeeta Bhatia, MD, PhD, John J. and Dorothy Wilson Professor, Electrical Engineering and Computer Science and Institute of Medical Engineering and Science Department at MIT, and Wolfram Goessling, MD, PhD, Ensign Professor of Medicine, Professor of Cellular and
More news about: American Liver Foundation
Dec 02, 2025, 07:00 ET Nanoscope Therapeutics' MCO-010 Optogenetic Therapy Featured at FLORetina-ICOOR 2025 Congress
three years from a single dose of MCO-010 is a remarkable outcome for patients with severe vision due to retinitis pigmentosa," said Jordi Monés, MD, PhD, Director of Institut de la Macula, and Barcelona Macula Foundation. "I am excited to share these results, as well as the strong safety profile of MCO-010,
More news about: Nanoscope Therapeutics
Dec 02, 2025, 07:00 ET AISA Pharma Announces Completion of Enrollment in Phase 2 RECONNOITER Trial of AISA-021 in Systemic Sclerosis-Related Raynaud's Phenomenon
World Congress on Systemic Sclerosis, which will be held March 5-7, 2026 in Athens, Greece, The data will be presented by Prof. Francesco Del Galdo, MD, PhD, the past President of EUSTAR, the European Scleroderma Clinical Trials and Research Group.Dr. Norman Stockbridge, of S & S Consulting,
More news about: Aisa Pharma
Dec 02, 2025, 06:00 ET HoneyNaps' AI Sleep-Diagnosis Software SOMNUM™ Selected as a 2025 Next Generation World Class Product at MOTIR Certification Ceremony
together 100 overseas buyers and 150 participating companies, resulting in 11 export contracts and MOUs valued at USD 16.3 million.Taekyoung (Sean) Ha, PhD, President of HoneyNaps USA, stated, "This designation as a Next Generation World Class Product reflects the global competitiveness and growth potential
More news about: HoneyNaps
Dec 02, 2025, 05:00 ET Global Wellness Awards Spotlight Leaders Transforming the World's $6.8 Trillion Wellness Economy
took her own life after a battle with mental illness. Gerry Bodeker, PhD—also a past recipient of the award in 2019—presented the award on behalf of the GWS Advisory Board.This year's award was presented to Meng-Mei Chen, PhD, a woman whose research and teaching are helping an entire industry understand
More news about: Global Wellness Summit
Dec 01, 2025, 23:30 ET Agora Powers Agnes AI to Launch Next-Generation AI Group Chat and Multi-Agent Collaboration System
presentation creation, multi-agent reasoning, and real-time team collaboration—driven by advanced multi-agent intelligence, led by CEO Bruce Yang, a PhD researcher at NUS and a former Microsoft/LinkedIn engineer.The platform combines several tools into one intelligent workspace. Its CoVibe
More news about: Agora, Inc.
Dec 01, 2025, 23:30 ET Agora Powers Agnes AI to Launch Next-Generation AI Group Chat and Multi-Agent Collaboration System
presentation creation, multi-agent reasoning, and real-time team collaboration—driven by advanced multi-agent intelligence, led by CEO Bruce Yang, a PhD researcher at NUS and a former Microsoft/LinkedIn engineer.The platform combines several tools into one intelligent workspace. Its CoVibe
More news about: Agora, Inc.
Dec 01, 2025, 16:06 ET Genetic Research Pinpoints a Lethal Risk Linked to Adams-Oliver Syndrome
Brian Gebelein, PhD, and Raphael Kopan, PhD, all within the Division
More news about: Cincinnati Children's Hospital Medical Center
Dec 01, 2025, 14:15 ET UT Health San Antonio pilot study explores ear acupressure for chronic pain relief in dementia care
Bianca Shieu, PhD, RN, assistant professor at the
More news about: UT Health San Antonio
Dec 01, 2025, 13:47 ET Sagrada Família Commemorates 100th Anniversary of Barnabas Tower
Barnabas was lit up. It also featured a conversation with Dr Jordi Faulí, head architect of the Sagrada Família, and Dr Chiara Curti, architect and PhD in Art History. Finally, it marked the opening of the exhibition "1925-2025. A hundred years of the completion of the tower of Barnabas. Gaudí's
More news about: Sagrada Familia
Dec 01, 2025, 11:19 ET From Canada to 50 States: CEO Interview with Neil Wiens on Replenish Nutrients' U.S. Breakout Strategy
biological amendmentsFilip ESGFIRE:Are next-generation formulations in development?Wiens:Yes. With a PhD geneticist and a plant pathologist on staff, we constantly explore new nutrient combinations and biological amendments. These innovations broaden our
More news about: Replenish Nutrients
Dec 01, 2025, 10:17 ET OncoPrecision Announces Oral Presentation of ONC001, a First-in-Class CD64-Targeting ADC for Monocytic Leukemia, at the 67th ASH Annual Meeting
targeting CD64 for the treatment of monocytic leukemia developed through patient-guided target and payload selectionPresenter: Gastón Soria, PhD, Co-Founder & Chief Scientific Officer, OncoPrecisionSession: 604. Molecular Pharmacology and Drug Resistance: Myeloid Neoplasms:
More news about: OncoPrecision Corporation
Dec 01, 2025, 10:17 ET OncoPrecision Announces Oral Presentation of ONC001, a First-in-Class CD64-Targeting ADC for Monocytic Leukemia, at the 67th ASH Annual Meeting
targeting CD64 for the treatment of monocytic leukemia developed through patient-guided target and payload selectionPresenter: Gastón Soria, PhD, Co-Founder & Chief Scientific Officer, OncoPrecisionSession: 604. Molecular Pharmacology and Drug Resistance: Myeloid Neoplasms:
More news about: OncoPrecision Corporation
Dec 01, 2025, 10:17 ET OncoPrecision gibt an, dass es auf der 67. ASH-Jahrestagung eine mündliche Präsentation zu ONC001, einem erstklassigen CD64-gerichteten ADC für monozytäre Leukämie, durchführen wird
CD64 for the treatment of monocytic leukemia developed through patient-guided target and payload selectionVortragender: Gastón Soria, PhD, Mitbegründer und Chief Scientific Officer, OncoPrecisionSitzung: 604. Molecular Pharmacology and Drug Resistance: Myeloid Neoplasms:
More news about: OncoPrecision Corporation
Dec 01, 2025, 09:14 ET Children's Hospital of Philadelphia Study Links Smartphone Ownership in Childhood to Increased Risk of Depression and Obesity in Youth
Ran Barzilay, MD, PhD, lead author of the study and a child-psychiatrist with the
More news about: Children's Hospital of Philadelphia
Dec 01, 2025, 09:09 ET New Published Article Discusses How to Make Hospitals Age-Friendly for People with Parkinson's
Hospital Care Recommendations show clinicians how to deliver them reliably for people with PD in real hospital workflows," said Peter Pronovost, MD, PhD, FCCM, lead author and Chief Quality and Transformation Officer at University Hospitals Cleveland Medical Center. "Hospitals are seeking disease-specific
More news about: Parkinson's Foundation
Dec 01, 2025, 09:02 ET Former DoW Acting CIO and DHS CIO John Zangardi Joins Knox Systems as Strategic Advisor
WASHINGTON and NEW YORK, Dec. 1, 2025 /PRNewswire/ -- Knox Systems today announced that John Zangardi, PhD, former Acting CIO for the Department of War and Chief Information Officer for the Department of Homeland Security, has joined Knox as a Strategic Advisor.
More news about: Knox Systems, Inc
Dec 01, 2025, 09:00 ET 100,000 Participants and Counting: Massive Global Genetic Dataset Powers Discoveries in Parkinson's Disease
focused on improving the understanding of the genetic architecture of Parkinson's disease in a global context. Led by Andrew Singleton, PhD, and Cornelis Blauwendraat, PhD, and made up of member organizations from around the world, GP2 is building the largest and most diverse database for Parkinson's and
More news about: Aligning Science Across Parkinson's
Dec 01, 2025, 09:00 ET Biocodex To Present New Data at the American Epilepsy Society (AES) 2025 Annual Meeting
optimal outcomes.Julie Ziobro, MD, PhD,Assistant Professor of PediatricsDivision of Pediatric Neurology,University of Michigan, Ann Arbor
More news about: Biocodex, Inc.